Aer Therapeutics, Inc.

Venture-backed company · Stage unknown· Raleigh, NC
Rounds on record
3
Latest round
Aug 7, 2026
Form D equity offering
Latest round size
$3.0M
Form D industry: Biotechnology
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

3 additional officers and directors, 4 additional investors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. $3M
    sold on Form D

    Filed a Form D on 7 Aug 2026: $3M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactSEC Form DFor Investors, lenders, service providersFinancing history →
  2. 3 investors
    named

    3 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  3. 6 directors
    board

    6 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
3

Financing history

3 rounds
  1. Aug 7, 2026
    Form D equity offering · $3.0M (form d sold) · 7 investors
    Fact Form D · “Aer Therapeutics, Inc. filed Form D: $3,000,000 sold of $3,000,000, Biotechnology”
  2. Jan 24, 2025
    Form D equity offering · $5.0M (form d sold) · 15 investors
    Pappas Ventures via Tom MathersCanaan Partners via TIM Shannon
    Fact Form D · “Aer Therapeutics, Inc. filed Form D: $5,000,000 sold of $5,000,000, Biotechnology”
  3. Dec 9, 2022
    Form D equity offering · $15.9M (form d sold)
    Canaan Partners via TIM Shannon
    Fact Form D · “Aer Therapeutics, Inc. Form D, first filed 2022-12-22”

Investors on record

7 edges

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 2 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 2 listingseach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

1 officer, 6 directors

Timeline

2 events
  1. Aug 19, 2026
    Aer Therapeutics, Inc. filed Form D: $3,000,000 sold of $3,000,000, Biotechnology
    Form D filed Fact Form D
  2. Feb 7, 2025
    Aer Therapeutics, Inc. filed Form D: $5,000,000 sold of $5,000,000, Biotechnology
    Form D filed Fact Form D

Evidence

34 observations
Every observation on this company
  • Entity type: Corporation Aug 19, 2026 Fact Form D
  • Entity type: Corporation Feb 7, 2025 Fact Form D
  • Form D industry group: Biotechnology Aug 19, 2026 Fact Form D
  • Form D industry group: Biotechnology Feb 7, 2025 Fact Form D
  • Amendment: false Aug 19, 2026 Fact Form D
  • Amendment: false Feb 7, 2025 Fact Form D
  • Revenue range (Form D): Decline to Disclose Aug 19, 2026 Fact Form D
  • Revenue range (Form D): Decline to Disclose Feb 7, 2025 Fact Form D
  • Incorporated: overFiveYears Aug 19, 2026 Fact Form D
  • Incorporated: overFiveYears Feb 7, 2025 Fact Form D
  • Jurisdiction: Delaware Aug 19, 2026 Fact Form D
  • Jurisdiction: Delaware Feb 7, 2025 Fact Form D
  • Amount sold (Form D): $3.0M Aug 19, 2026 Fact Form D
  • Amount sold (Form D): $5.0M Feb 7, 2025 Fact Form D
  • Offering amount (Form D): $3.0M Aug 19, 2026 Fact Form D
  • Offering amount (Form D): $5.0M Feb 7, 2025 Fact Form D
  • Exemptions: 06b Aug 19, 2026 Fact Form D
  • Exemptions: 06b Feb 7, 2025 Fact Form D
  • First sale: 2026-08-07 Aug 19, 2026 Fact Form D
  • First sale: 2025-01-24 Feb 7, 2025 Fact Form D
  • Investors (Form D): 7 Aug 19, 2026 Fact Form D
  • Investors (Form D): 15 Feb 7, 2025 Fact Form D
  • Minimum investment (Form D): 0 Aug 19, 2026 Fact Form D
  • Minimum investment (Form D): 0 Feb 7, 2025 Fact Form D
  • Securities offered: Debt, option Aug 19, 2026 Fact Form D
  • Securities offered: equity Feb 7, 2025 Fact Form D
  • Office address: Aug 19, 2026 Fact Form D
  • Office address: Feb 7, 2025 Fact Form D
  • Listed on portfolio page: Oct 1, 2026 Fact Firm website
  • Listed on portfolio page: Oct 1, 2026 Fact
  • Listed on portfolio page: Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Sep 16, 2026 Fact
  • Listed on portfolio page: Sep 15, 2026 Fact Firm website
  • Listed on portfolio page: Sep 15, 2026 Fact

Relationships across DFX

1 capital path
Capital chain

Aer Therapeutics, Inc. sits on 1 traced path of capital across the graphs.

Allocator to VC fund to manager to company

DFX traced 1 path of capital through this record

Every record on each path, what it committed or lent, and as of when.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.

Checking your plan…

Record history

2 dated events on the change ledger, latest event first
  • Form D filed
    2026-08-19source on record
  • Form D filed
    2025-02-07source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.